07:37 AM EST, 01/13/2025 (MT Newswires) -- Pediatrix Medical Group ( MD ) said Monday it has appointed Executive Chair Mark Ordan as chief executive officer.

Ordan succeeds James Swift, the company said.

Pediatrix also said it expects its 2024 adjusted earnings before interest, taxes, depreciation, and amortization to reach or exceed the high end of its $205 million-to-$215 million guidance range.

Shares of Pediatrix were up 2% during recent premarket activity.

Price: 12.70, Change: +0.26, Percent Change: +2.09